Trial intelligence / Profile preview

PRP vs ozone vs corticosteroid for post-ankle bursitis pain

IRCT20241211064021N3Phase 3Completed

Sponsor
Hamadan University of Medical Sciences
Start
Apr 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of platelet-rich plasma and medical ozonated water in bursitis (3 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoint: Pain reduction. Started Apr 2025; status: completed.

02

Drugs

platelet-rich plasmamedical ozonated water
03

Conditions

bursitis

Beyond the preview

Go deeper on IRCT20241211064021N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20241211064021N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call